{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:30:50Z","timestamp":1788996650846,"version":"build-2803163510"},"reference-count":69,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"King Abdullah International Medical Research Center (KAIMRC)","award":["RA-18\/021A (PI: Ahmed Bakillah)"],"award-info":[{"award-number":["RA-18\/021A (PI: Ahmed Bakillah)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Cardiovascular disease (CVD) is the leading cause of mortality in obese patients with type 2 diabetes mellitus (T2DM). Conventional biomarkers often fail to detect early endothelial dysfunction and oxidative stress. Haptoglobin (Hp), an acute-phase protein with antioxidant and hemoglobin-binding properties, may indicate vascular injury. While plasma Hp (pl-Hp) reflects systemic inflammation, urinary Hp (u-Hp) could signal renal and microvascular damage. We hypothesize that elevated u-Hp and altered pl-Hp levels are associated with increased oxidized LDL and may serve as sensitive indicators of early vascular injury, thereby identifying obese patients with T2DM at higher cardiovascular risk. This study aims to investigate the associations between u-Hp, pl-Hp, and oxidized LDL (ox-LDL) in obese patients with T2DM, and to evaluate the potential role of Hp as an early biomarker of cardiovascular risk in this high-risk population. Methods and Results: The study included 57 patients with T2DM (mean age 61 \u00b1 10 years, HbA1c 8.66 \u00b1 1.60%, and BMI 35.15 \u00b1 6.65 kg\/m2). Notably, 95% of the patients had hypertension, 82% had dyslipidemia, and 59% had an estimated glomerular filtration rate (eGFR) &lt; 60 mL\/min\/1.73 m2. Pl-Hp and u-Hp concentrations, as well as ox-LDL levels, were assessed using an enzyme-linked immunosorbent assay (ELISA). Correlations and multivariate regression analyses were employed to investigate the associations between Hp, ox-LDL, and clinical cardiovascular risk factors. Pl-Hp was positively correlated with ox-LDL (r = 0.358, p &lt; 0.006) and negatively correlated with C-reactive protein (CRP) (r = \u22120.364, p &lt; 0.013), while u-Hp correlated positively with HbA1C and apoB levels (r = 0.298, p &lt; 0.030 and r = 0.310, p &lt; 0.021, respectively). Multivariate analysis indicated that pl-Hp, but not u-Hp, was independently associated with ox-LDL (\u03b2 = 0.536, p &lt; 0.027) after adjusting for potential confounding factors, including age, gender, BMI, HbA1c, liver enzymes, hs-CRP and creatinine. The Stepwise analysis identified IL-6 as the most significant predictor of cardiovascular disease risk, suggesting its pivotal role in subclinical vascular inflammation among obese individuals with T2DM. Furthermore, the significant positive association between pl-Hp and ox-LDL was stronger in patients with declining renal function as expressed by the estimated glomerular filtration rate (eGFR) (eGFR &lt; 30 mL\/min\/1.73 m2: \u03b2 = 2.173, p &lt; 0.031 and eGFR 30\u201359 mL\/min\/1.73 m2: \u03b2 = 1.318, p &lt; 0.002). This association also appeared in early and low-normal ranges of serum albumin: creatinine ratio (s-ACR) (s-ACR &lt; 0.2714 mg\/mmol: \u03b2 = 2.304, p &lt; 0.005 and s-ACR 0.2714\u20130.3649 mg\/mmol: \u03b2 = 1.000, p &lt; 0.041), suggesting that pl-Hp and ox-LDL rise before overt kidney damage. Elevated IL-6 (\u226532.93 pg\/mL) further strengthened this link (\u03b2 = 1.037, p &lt; 0.005), highlighting the role of inflammation in amplifying oxidative stress and acute-phase responses. Conclusions: Taken together, these findings emphasize the interconnected contributions of renal impairment, inflammation, and oxidative stress to vascular injury. While these results need to be confirmed in larger prospective longitudinal studies, monitoring pl-Hp levels in conjunction with inflammatory and kidney function markers could be a sensitive and non-invasive way to identify early CVD risk in high-risk groups, such as obese patients with T2DM.<\/jats:p>","DOI":"10.3390\/nu17172883","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:29:07Z","timestamp":1757327347000},"page":"2883","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Association of Haptoglobin with Oxidized LDL in Obese Patients with Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-1976","authenticated-orcid":false,"given":"Ahmed","family":"Bakillah","sequence":"first","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Al Ahsa 36428, Saudi Arabia"},{"name":"Biomedical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maram","family":"Al Subaiee","sequence":"additional","affiliation":[{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khamis Khamees","family":"Obeid","sequence":"additional","affiliation":[{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman Farouk","family":"Soliman","sequence":"additional","affiliation":[{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6437-3074","authenticated-orcid":false,"given":"Abeer","family":"Al Otaibi","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Al Ahsa 36428, Saudi Arabia"},{"name":"Biomedical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindiyan Al Shaikh","family":"Mubarak","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Al Ahsa 36428, Saudi Arabia"},{"name":"Biomedical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara Abdullah","family":"Al Mihmadi","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Al Ahsa 36428, Saudi Arabia"},{"name":"Biomedical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahinaz Faisal","family":"Bashir","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Al Ahsa 36428, Saudi Arabia"},{"name":"Biomedical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al Arab","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Al Ahsa 36428, Saudi Arabia"},{"name":"Biomedical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Al Hussaini","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Al Ahsa 36428, Saudi Arabia"},{"name":"Biomedical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ahmed","family":"Al Qarni","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Al Ahsa 36428, Saudi Arabia"},{"name":"Biomedical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1570161115666171010115119","article-title":"Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications","volume":"17","author":"Jayyousi","year":"2019","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111816","DOI":"10.1016\/j.diabres.2024.111816","article-title":"Glucose lowering drug or strategy dependent impact of weight reduction on the prevention of CVD outcomes in Type 2 diabetes: A systematic review of CVOTs","volume":"216","author":"Lalic","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7092151","DOI":"10.1155\/2019\/7092151","article-title":"Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease","volume":"2019","author":"Steven","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2012.02.011","article-title":"Haptoglobin genotype and its role in determining heme-iron mediated vascular disease","volume":"66","author":"Goldenstein","year":"2012","journal-title":"Pharmacol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/ars.2009.2793","article-title":"Haptoglobin: Basic and clinical aspects","volume":"12","author":"Levy","year":"2010","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abbi.1996.0073","article-title":"Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation","volume":"326","author":"Miller","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/cdd.2013.113","article-title":"Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damage","volume":"20","author":"Schaer","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sajib, M., Wu, H., Fristedt, R., and Undeland, I. (2021). Hemoglobin-mediated lipid oxidation of herring filleting co-products during ensilaging and its inhibition by pre-incubation in antioxidant solutions. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-98997-4"},{"key":"ref_9","first-page":"184","article-title":"Haptoglobin as a Biomarker","volume":"15","author":"Naryzny","year":"2021","journal-title":"Biochem. Mosc. Suppl. B Biomed. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1021\/bi0362626","article-title":"Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL","volume":"43","author":"Bamm","year":"2004","journal-title":"Biochemistry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","article-title":"Biological and clinical significance of haptoglobin polymorphism in humans","volume":"42","author":"Langlois","year":"1996","journal-title":"Clin. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10408363.2023.2285929","article-title":"Unlocking the link between haptoglobin polymorphism and noninfectious human diseases: Insights and implications","volume":"61","author":"Delanghe","year":"2024","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2009.09.002","article-title":"The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque","volume":"209","author":"Moreno","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jacc.2012.09.063","article-title":"Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin","volume":"61","author":"Cahill","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.11.051","article-title":"Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes","volume":"75","author":"Carew","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/dc21-1429","article-title":"Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial","volume":"45","author":"Warren","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100681","DOI":"10.1016\/j.ajpc.2024.100681","article-title":"Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial","volume":"18","author":"Cahill","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0021-9150(97)00089-0","article-title":"Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery","volume":"132","author":"Delanghe","year":"1997","journal-title":"Atherosclerosis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2004.05.005","article-title":"Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism","volume":"176","author":"Brouwers","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/gtmb.2011.0246","article-title":"Haptoglobin 2-2 genotype is associated with increased risk of type 2 diabetes mellitus in northern Chinese","volume":"16","author":"Shi","year":"2012","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e006565","DOI":"10.1161\/JAHA.117.006565","article-title":"Haptoglobin 2-2 Phenotype Is Associated with Increased Acute Kidney Injury After Elective Cardiac Surgery in Patients with Diabetes Mellitus","volume":"6","author":"Feng","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"144786","DOI":"10.1016\/j.gene.2020.144786","article-title":"Haptoglobin genotype 2-2 associated with atherosclerosis in patients with ischemic stroke","volume":"752","author":"Merkler","year":"2020","journal-title":"Gene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1475-2840-12-31","article-title":"Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study","volume":"12","author":"Adams","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/dc19-1295","article-title":"Association of Urine Haptoglobin with Risk of All-Cause and Cause-Specific Mortality in Individuals with Type 2 Diabetes: A Transethnic Collaborative Work","volume":"43","author":"Liu","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12265-012-9361-z","article-title":"Haptoglobin genotype and its role in diabetic cardiovascular disease","volume":"5","author":"Costacou","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Somer, S., and Levy, A.P. (2020). The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010287"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100625","DOI":"10.1016\/j.ajpc.2023.100625","article-title":"Haptoglobin genotype is a risk factor for coronary artery disease in prediabetes: A case-control study","volume":"17","author":"Mewborn","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2337\/diaclin.34.3.148","article-title":"Role of Haptoglobin in Health and Disease: A Focus on Diabetes","volume":"34","author":"MacKellar","year":"2016","journal-title":"Clin. Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.endinu.2018.07.008","article-title":"Haptoglobin levels are influenced by Hp1-Hp2 polymorphism, obesity, inflammation, and hypertension in type 2 diabetes mellitus","volume":"66","author":"Rodrigues","year":"2019","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lee, C.W., Cheng, T.M., Lin, C.P., and Pan, J.P. (2013). Plasma haptoglobin concentrations are elevated in patients with coronary artery disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076817"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13105-012-0186-7","article-title":"Haptoglobin and the inflammatory and oxidative status in experimental diabetic rats: Antioxidant role of haptoglobin","volume":"69","author":"Jelena","year":"2013","journal-title":"J. Physiol. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/ki.2013.57","article-title":"Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes","volume":"83","author":"Bhensdadia","year":"2013","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1007\/s00467-023-06012-x","article-title":"Evaluation of urinary haptoglobin level as a biomarker of diabetic nephropathy in children with type 1 diabetes","volume":"38","author":"Bezen","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2016-2094","article-title":"Urinary Haptoglobin Predicts Rapid Renal Function Decline in Asians with Type 2 Diabetes and Early Kidney Disease","volume":"101","author":"Liu","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-019-0808-2","article-title":"Association between serum haptoglobin and carotid arterial functions: Usefulness of a targeted metabolomics approach","volume":"18","author":"Wang","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1055\/a-0955-6563","article-title":"Urine Haptoglobin\/Creatinine Ratio Correlates with Tubular Injury Biomarkers and Severity of Albuminuria in Type 2 Diabetes Patients","volume":"51","author":"Wang","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e030288","DOI":"10.1161\/JAHA.123.030288","article-title":"Relationship Between Time-Varying Achieved High-Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study","volume":"12","author":"Warren","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Xu, C., Khin, L.W., Tam, H.Z., Goh, L.L., Koh, E.T., Dalan, R., and Leong, K.P. (2024). Haptoglobin 2-2 genotype is associated with increased risk of cardiovascular disease in patients with rheumatoid arthritis: A matched case-control study. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1442858"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Song, J., Cao, C., Wang, Z., Li, H., Yang, L., Kang, J., Meng, H., Li, L., and Liu, J. (2024). Mechanistic insights into the regression of atherosclerotic plaques. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1473709"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jacc.2015.07.076","article-title":"The Risk of Coronary Heart Disease Associated with Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype","volume":"66","author":"Cahill","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","first-page":"2371","article-title":"Plasma Haptoglobin as A Potential Biomarker for Coronary Artery Disease in Young Hypertensive Adults","volume":"23","author":"Bakrim","year":"2024","journal-title":"IIUM Med. J. Malays."},{"key":"ref_42","unstructured":"Mayo (2025, April 09). Haptoglobin, Serum. Mayo Clinic Laboratories. Available online: https:\/\/www.mayocliniclabs.com\/test-catalog\/Overview\/9168\/."},{"key":"ref_43","unstructured":"UCSF (2025, April 09). Haptoglobin Blood Test. UCSF Health. Available online: https:\/\/www.ucsfhealth.org\/medical-tests\/haptoglobin-blood-test."},{"key":"ref_44","unstructured":"Evexia (2025, April 09). Evexia Diagnostics. Available online: https:\/\/www.evexiadiagnostics.com\/test-menu\/oxidized-low-density-lipoprotein-oxldl\/."},{"key":"ref_45","unstructured":"Carr, A. (2025, April 09). Cardiovascular Biomarkers: Oxidized LDL. OptimalDx (Clinical Context). Available online: https:\/\/www.optimaldx.com\/research-blog\/cardiovascular-biomarkers-oxidized-ldl."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e70014","DOI":"10.1111\/1753-0407.70014","article-title":"Overview of oxidative stress and inflammation in diabetes","volume":"16","author":"Segev","year":"2024","journal-title":"J. Diabetes"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jiang, H., Zhou, Y., Nabavi, S.M., Sahebkar, A., Little, P.J., Xu, S., Weng, J., and Ge, J. (2022). Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.925923"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.1021\/bi970258a","article-title":"Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: Antioxidant role of haptoglobin","volume":"36","author":"Miller","year":"1997","journal-title":"Biochemistry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/01.RES.0000251741.65179.56","article-title":"Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo","volume":"99","author":"Asleh","year":"2006","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2006.08.044","article-title":"Haptoglobin genotype determines myocardial infarct size in diabetic mice","volume":"49","author":"Blum","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4239\/wjd.v12.i3.206","article-title":"Progress on haptoglobin and metabolic diseases","volume":"12","author":"Wan","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/jc.2019-00723","article-title":"Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women with Type 1 Diabetes","volume":"104","author":"Kelly","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Thangasparan, S., Kamisah, Y., Ugusman, A., Mohamad Anuar, N.N., and Ibrahim, N. (2024). Unravelling the Mechanisms of Oxidised Low-Density Lipoprotein in Cardiovascular Health: Current Evidence from In Vitro and In Vivo Studies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413292"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/dom.15991","article-title":"Key biomarkers in type 2 diabetes patients: A systematic review","volume":"27","author":"Le","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"107865","DOI":"10.1016\/j.diabres.2019.107865","article-title":"Serum haptoglobin levels are associated with renal function decline in type 2 diabetes mellitus patients in a Chinese Han population","volume":"156","author":"Huang","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0035-9203(94)90287-9","article-title":"Evaluation of C-reactive protein and haptoglobin as malaria episode markers in an area of high transmission in Africa","volume":"88","author":"Hurt","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/jvim.12568","article-title":"Plasma C-reactive protein and haptoglobin concentrations in critically ill neonatal foals","volume":"29","author":"Zabrecky","year":"2015","journal-title":"J. Vet. Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"Ngwa","year":"2022","journal-title":"Mol. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Schaer, D.J., Vinchi, F., Ingoglia, G., Tolosano, E., and Buehler, P.W. (2014). Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front. Physiol., 5.","DOI":"10.3389\/fphys.2014.00415"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40200-021-00788-1","article-title":"Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring","volume":"20","author":"Picheth","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.semnephrol.2004.06.026","article-title":"Oxidative stress in uremia: Nature, mechanisms, and potential consequences","volume":"24","author":"Vaziri","year":"2004","journal-title":"Semin. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12933-023-01907-3","article-title":"Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: A multicenter retrospective study","volume":"22","author":"Lin","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12933-023-01796-6","article-title":"Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes","volume":"22","author":"Tao","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1111\/cts.13636","article-title":"Association between serum albumin to serum creatinine ratio and mortality risk in patients with heart failure","volume":"16","author":"Li","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2174\/138161209789058093","article-title":"Oxidative stress, endothelial dysfunction and atherosclerosis","volume":"15","author":"Victor","year":"2009","journal-title":"Curr. Pharm. Des."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/17\/2883\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:41:11Z","timestamp":1760035271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/17\/2883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":69,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["nu17172883"],"URL":"https:\/\/doi.org\/10.3390\/nu17172883","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,6]]}}}